Covalent pH-Sensitive Labeling for Antibody Internalization Studies
Covalently labels primary amines on antibodies.
Strong fluorescence with low background.
Fluorescence increases in acidic compartments.
Approximately 30 minutes of hands-on work with a total assay time of 2.5 hours.
Supports antibodies from different species and subclasses, as well as ADCs.
Includes all required reagents and a standardized protocol.
| Cat. No. | Molecule | Product Description | Order Now |
|---|---|---|---|
pH-Sensitive Fluorescent Dye
Reaction Buffer
Quencher Reagent
Desalting Spin column
Purification & Storage Buffer
Anti-Her2 Ab and Human IgG1 isotype control were labeled using pH-Sensitive Fluorescent Dye Antibody Labeling Kit (Cat. No. ALK-A004). SK-BR-3 cells were treated with Dye Labeled Anti-Her2 Ab and Dye Labeled Isotype Control separately at 37℃ for 4 hours, then analysis by Flow cytometric. APC signal was used to evaluate the internalization signal.
Request Protocol
Anti-CD20 Ab and Human IgG1 isotype control were labeled using pH-Sensitive Fluorescent Dye Antibody Labeling Kit (Cat. No. ALK-A004). Raji cells were treated with Dye Labeled Anti-CD20 Ab and Dye Labeled Isotype Control separately at 37℃ for 4 hours, then analysis by Flow cytometric. APC signal was used to evaluate the internalization signal.
Request Protocol
For human IgG antibodies and ADCs.
Fc-Specific Binding | No Antibody Pre-Labeling or Purification
View Product Details
Human IgG antibodies and human IgG-based ADCs
Approximately 10-minute reagent–antibody complex formation
No antibody pre-labeling or post-label purification
Antibodies from different species and subclasses, as well as ADCs
Primary amine–reactive covalent labeling
Approximately 30 minutes of hands-on work with spin-column purification
| Category |
Ready-to-Use Internalization Assay
|
Covalent Labeling Internalization Assay
|
|---|---|---|
|
|
Fc-specific non-covalent labeling | Primary amine-based covalent labeling |
|
|
Human IgG antibodies & ADCs | Antibodies/ADCs from different species and subclasses |
|
|
Approximately 10 min antibody labeling | 30 min hands-on work |
|
|
Flow cytometry / Cell imaging | Flow cytometry / Cell imaging |
|
|
|
|
|
|
No purification required, approximately 10 min labeling | Broad compatibility across antibody species and subclasses, as well as ADCs |
‘ADC Potency Analysis and Quality Control Technology Breakthrough’ Webinar Series
ACROBiosystems proudly presents the flagship 'ADC Potency Analysisand Quality Control Technology Breakthrough' live webinar series. This series will systematicallydeconstruct critical aspects ofADC drug development through five coremodules-from potency analysis to quality control technologiesempowering breakthroughs in ADC therapeutics by overcoming keytechnical bottlenecks.
Watch NowAddressing Challenges in Antibody-Drug Conjugate Development
Here is the brief recap of the webinar:ADCs have the potential to enable 'precision medicine' with a wide market reach.Challenges in ADCs include managing Target Affinity, enhancing payload conjugation, and assessing Payload Delivery in vivo Pharmacokinetics. We can provide high-quality solutions to address these challenges.
Watch NowBuilding the Perfect Antibody-based Therapeutic from Selection to Engineering and Manufacturing
In this webinar, discover how advanced techniques such as Al-driven candidate selection optimization of antibody sequences, and precise conjugation methods come together to address some of the current challenges in antibody-based therapeutics.
Watch Now [North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland